Audit of use and overuse of serum protein immunofixation electrophoresis and serum free light chain assay in tertiary health care a case for algorithmic testing to optimize laboratory utilization

Christopher Heaton, Shikhar G. Vyas, Gurmukh Singh

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: Overuse of laboratory tests is a persistent issue. We examined the use and overuse of serum immunofixation electrophoresis and serum free light chain assays to develop an algorithm for optimizing utilization. Methods: A retrospective review of all tests, for investigation of monoclonal gammopathies, for all patients who had any of these tests done from April 24, 2014, through July 25, 2014, was carried out. The test orders were categorized as warranted or not warranted according to criteria presented in the article. Results: A total of 237 patients were tested, and their historical records included 1,503 episodes of testing for one or more of serum protein electrophoresis, serum immunofixation electrophoresis, and serum free light chain assays. Only 46% of the serum immunofixation and 42% serum free light chain assays were warranted. Proper utilization, at our institution alone, would have obviated $64,182.95/year in health care costs, reduced laboratory cost of reagent alone by $26,436.04/year, and put $21,904.92/year of part B reimbursement at risk. Conclusions: Fewer than half of the serum immunofixation and serum free light chain assays added value. The proposed algorithm for testing should improve utilization. Risk to part B billing may be a disincentive to reducing test utilization.

Original languageEnglish (US)
Pages (from-to)531-537
Number of pages7
JournalAmerican Journal of Clinical Pathology
Volume145
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Tertiary Healthcare
Electrophoresis
Blood Proteins
Delivery of Health Care
Light
Serum
Paraproteinemias
Health Care Costs
Motivation
Costs and Cost Analysis

Keywords

  • Algorithmic testing
  • Appropriateness of laboratory utilization
  • Laboratory cost of health care
  • Serum free light chain assay
  • Serum protein electrophoresis
  • Serum protein immunofixation electrophoresis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{0b08b840f14b46a4b0857ce8c5af543b,
title = "Audit of use and overuse of serum protein immunofixation electrophoresis and serum free light chain assay in tertiary health care a case for algorithmic testing to optimize laboratory utilization",
abstract = "Objectives: Overuse of laboratory tests is a persistent issue. We examined the use and overuse of serum immunofixation electrophoresis and serum free light chain assays to develop an algorithm for optimizing utilization. Methods: A retrospective review of all tests, for investigation of monoclonal gammopathies, for all patients who had any of these tests done from April 24, 2014, through July 25, 2014, was carried out. The test orders were categorized as warranted or not warranted according to criteria presented in the article. Results: A total of 237 patients were tested, and their historical records included 1,503 episodes of testing for one or more of serum protein electrophoresis, serum immunofixation electrophoresis, and serum free light chain assays. Only 46{\%} of the serum immunofixation and 42{\%} serum free light chain assays were warranted. Proper utilization, at our institution alone, would have obviated $64,182.95/year in health care costs, reduced laboratory cost of reagent alone by $26,436.04/year, and put $21,904.92/year of part B reimbursement at risk. Conclusions: Fewer than half of the serum immunofixation and serum free light chain assays added value. The proposed algorithm for testing should improve utilization. Risk to part B billing may be a disincentive to reducing test utilization.",
keywords = "Algorithmic testing, Appropriateness of laboratory utilization, Laboratory cost of health care, Serum free light chain assay, Serum protein electrophoresis, Serum protein immunofixation electrophoresis",
author = "Christopher Heaton and Vyas, {Shikhar G.} and Gurmukh Singh",
year = "2016",
month = "4",
day = "1",
doi = "10.1093/AJCP/AQW026",
language = "English (US)",
volume = "145",
pages = "531--537",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Audit of use and overuse of serum protein immunofixation electrophoresis and serum free light chain assay in tertiary health care a case for algorithmic testing to optimize laboratory utilization

AU - Heaton, Christopher

AU - Vyas, Shikhar G.

AU - Singh, Gurmukh

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Objectives: Overuse of laboratory tests is a persistent issue. We examined the use and overuse of serum immunofixation electrophoresis and serum free light chain assays to develop an algorithm for optimizing utilization. Methods: A retrospective review of all tests, for investigation of monoclonal gammopathies, for all patients who had any of these tests done from April 24, 2014, through July 25, 2014, was carried out. The test orders were categorized as warranted or not warranted according to criteria presented in the article. Results: A total of 237 patients were tested, and their historical records included 1,503 episodes of testing for one or more of serum protein electrophoresis, serum immunofixation electrophoresis, and serum free light chain assays. Only 46% of the serum immunofixation and 42% serum free light chain assays were warranted. Proper utilization, at our institution alone, would have obviated $64,182.95/year in health care costs, reduced laboratory cost of reagent alone by $26,436.04/year, and put $21,904.92/year of part B reimbursement at risk. Conclusions: Fewer than half of the serum immunofixation and serum free light chain assays added value. The proposed algorithm for testing should improve utilization. Risk to part B billing may be a disincentive to reducing test utilization.

AB - Objectives: Overuse of laboratory tests is a persistent issue. We examined the use and overuse of serum immunofixation electrophoresis and serum free light chain assays to develop an algorithm for optimizing utilization. Methods: A retrospective review of all tests, for investigation of monoclonal gammopathies, for all patients who had any of these tests done from April 24, 2014, through July 25, 2014, was carried out. The test orders were categorized as warranted or not warranted according to criteria presented in the article. Results: A total of 237 patients were tested, and their historical records included 1,503 episodes of testing for one or more of serum protein electrophoresis, serum immunofixation electrophoresis, and serum free light chain assays. Only 46% of the serum immunofixation and 42% serum free light chain assays were warranted. Proper utilization, at our institution alone, would have obviated $64,182.95/year in health care costs, reduced laboratory cost of reagent alone by $26,436.04/year, and put $21,904.92/year of part B reimbursement at risk. Conclusions: Fewer than half of the serum immunofixation and serum free light chain assays added value. The proposed algorithm for testing should improve utilization. Risk to part B billing may be a disincentive to reducing test utilization.

KW - Algorithmic testing

KW - Appropriateness of laboratory utilization

KW - Laboratory cost of health care

KW - Serum free light chain assay

KW - Serum protein electrophoresis

KW - Serum protein immunofixation electrophoresis

UR - http://www.scopus.com/inward/record.url?scp=84981293920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981293920&partnerID=8YFLogxK

U2 - 10.1093/AJCP/AQW026

DO - 10.1093/AJCP/AQW026

M3 - Article

C2 - 27124940

AN - SCOPUS:84981293920

VL - 145

SP - 531

EP - 537

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -